Malignant Pheochromocytomas and Paragangliomas: A Phase II Study of Therapy with High-Dose 131I-Metaiodobenzylguanidine (131I-MIBG) PAUL A FITZGERALD, ROBERT E GOLDSBY, JOHN P HUBERTY, DAVID C PRICE, RANDALL A HAWKINS, JANET J VEATCH, FILEMON DELA CRUZ, THIERRY M JAHAN, CHARLES A LINKER, LLOYD DAMON, and KATHERINE K MATTHAY |
 |
|
|
To view this item, select one of the options below: |
|
|
|
Sign In |
 |
Academy Members: Log in at the Academy site |
|
|
|
|
Librarians: Activate your Institutional Subscription |
|
|
|
|
Sign Up |
|
Individuals: Join the Academy |
|
|
|
|
Institutions: Subscribe for Full Access |
|
|
|
|
Purchase Short-Term Access |
|
Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$15.00. |
|
Pay for Admission - You may access all content in Annals of the New York Academy of Sciences Online (from the computer you are currently using) for 24 hours for US$30.00. |
|
|
Regain Access - You can regain access to a recent Pay per Article or Pay for Admission purchase if your access period has not yet expired. |
|
|
|
